Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: Relationships to clinical tumour behaviour

Clinical Endocrinology

Volumn 58, Issue 2, 2003, Pages 141-150

  McCabe, C J ^a   Khaira, J S ^a   Boelaert, K ^a   Heaney, A P ^b   Tannahill, L A ^a   Hussain, S ^a   Mitchell, R ^a   Olliff, J ^a   Sheppard, M C ^a   Franklyn, J A ^a   Gittoes, N J L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GENE PRODUCT; PROTEIN PBF; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MITOSIS; ONCOGENE; PITUITARY TUMOR TRANSFORMING GENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADENOMA; ADULT; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0037322597     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01598.x     Document Type: Article

References (34)

1. Abbass, S.A., Asa, S.L. & Ezzat, S. (1997) Altered expression of fibroblast growth factor receptors in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 82, 1160-1166.
2. Alexander, J.M., Bikkal, H.A., Zervas, N.T., Laws, E. Jr & Klibanski, A. (1996) Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 81, 783-790.
3. Atkin, S.L., Green, V.L., Hipkin, L.J., Landolt, A.M., Foy, P.M., Jeffreys, R.V. & White, M.C. (1997) A comparison of proliferation indices in human anterior pituitary adenomas using formalin-fixed tissue and in vitro cell culture. Journal of Neurosurgery, 87, 85-88.
4. Atkin, S.L., Jeffreys, R.V., Foy, P.M., Hipkin, L., Radcliffe, J. & White, M.C. (1995) Effects of basic fibroblastic growth factor on the function and proliferation of human clinically non-functional pituitary adenomas which secreted glycoprotein hormones in vitro. Journal of Endocrinology, 144, 173-178.
5. Atkin, S.L., Landolt, A.M., Jeffreys, R.V., Diver, M., Radcliffe, J. & White, M.C. (1993) Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation. Journal of Clinical Endocrinology and Metabolism, 77, 831-837.
6. Baird, A., Mormede, P., Ying, S.Y., Wehrenberg, W.B., Ueno, N., Ling, N. & Guillemin, R. (1985) A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proceedings of the National Academy of Sciences of the United States of America, 82, 5545-5549.
7. Buchfelder, M., Fahlbusch, R., Adams, E.F., Kiesewetter, F. & Thierauf, P. (1996) Proliferation parameters for pituitary adenomas. Acta Neurochirurgica Supplementum, 65, 18-21.
8. Castro, M.G., Davis, J.R., Xiong, W. & Lowenstein, P.R. (1999) Recent developments in gene therapy: applications for the treatment of pituitary tumours. Best Practice and Research Clinical Endocrinology and Metabolism, 13, 431-449.
9. Chien, W. & Pei, L. (2000) A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. Journal of Biological Chemistry, 275, 19422-19427.
10. Daniely, M., Aviram, A., Adams, E.F., Buchfelder, M., Barkai, G., Fahlbusch, R., Goldman, B. & Friedman, E. (1998) Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 83, 1801-1805.
11. Edal, A.L., Skjodt, K. & Nepper-Rasmussen, H.J. (1997) SIPAP - a new MR classification for pituitary adenomas. Acta Radiologica, 38, 30-36.
12. Ezzat, S., Zheng, L., Zhu, X.F., Wu, G.E. & Asa, S.L. (2002) Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. Journal of Clinical Investigation, 109, 69-78.
13. Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent? Journal of the National Cancer Institute, 82, 4-6.
14. Gittoes, N.J., McCabe, C.J., Verhaeg, J., Sheppard, M.C. & Franklyn, J.A. (1997) Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctioning tumors of the anterior pituitary. Journal of Clinical Endocrinology and Metabolism, 82, 1960-1967.
15. Grothe, C., Meisinger, C., Hertenstein, A., Kurz, H. & Wewetzer, K. (1997) Expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 messenger RNAs in spinal ganglia and sciatic nerve: regulation after peripheral nerve lesion. Neuroscience, 76, 123-135.
16. Heaney, A.P., Horwitz, G.A., Wang, Z., Singson, R. & Melmed, S. (1999) Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nature Medicine, 5, 1317-1321.
17. Heaney, A.P., Singson, R., McCabe, C.J., Nelson, V., Nakashima, M. & Melmed, S. (2000) Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet, 355, 716-719.
18. Hui, A.B., Pang, J.C., Ko, C.W. & Ng, H.K. (1999) Detection of chromosomal imbalances in growth hormone-secreting pituitary tumors by comparative genomic hybridization. Human Pathology, 30, 1019-1023.
19. Ishikawa, H., Heaney, A.P., Yu, R., Horwitz, G.A. & Melmed, S. (2001) Human pituitary tumor-transforming gene induces angiogenesis. Journal of Clinical Endocrinology and Metabolism, 86, 867-874.
20. Knosp, E., Kitz, K. & Perneczky, A. (1989) Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery, 25, 927-930.
21. Larsen, J.B., Schroder, H.D., Sorensen, A.G., Bjerre, P. & Heim, S. (1999) Simple numerical chromosome aberrations characterize pituitary adenomas. Cancer Genetics and Cytogenetics, 114, 144-149.
22. Larson, G.H., Koos, R.D., Sortino, M.A. & Wise, P.M. (1990) Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay. Endocrinology, 126, 927-932.
23. Li, Y., Koga, M., Kasayama, S., Matsumoto, K., Arita, N., Hayakawa, T. & Sato, B. (1992) Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 75, 1436-1441.
24. Pei, L. (2001) Identification of c-myc as a down-stream target for pituitary rumor-transforming gene. Journal of Biological Chemistry, 276, 8484-8491.
25. Pei, L. & Melmed, S. (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Molecular Endocrinology, 11, 433-441.
26. Romero, F., Multon, M.C., Ramos-Morales, F., Dominguez, A., Bernal, J.A., Pintor-Toro, J.A. & Tortolero, M. (2001) Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Research, 29, 1300-1307.
27. Thapar, K., Kovacs, K., Scheithauer, B.W., Stefaneanu, L., Horvath, E., Pernicone, P.J., Murray, D. & Laws, E. Jr (1996a) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery, 38, 99-106.
28. Thapar, K., Scheithauer, B.W., Kovacs, K., Pernicone, P.J. & Laws, E. Jr (1996b) p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery, 38, 763-770.
29. Wilson, C.B. (1990) Role of surgery in the management of pituitary tumors. Neurosurgery Clinics of North America, 1, 139-159.
30. Yu, R., Heaney, A., Lu, W., Chen, J. & Melmed, S. (2000) Pituitary tumor transforming gene (PTTG) causes aneuploidy and p53-dependent and p53-independent apoptosis. Journal of Biological Chemistry. 275, 36502-5.
31. Zhang, X., Horwitz, G.A., Heaney, A.P., Nakashima, M., Prezant, T.R., Bronstein, M.D. & Melmed, S. (1999a) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 84, 761-767.
32. Zhang, X., Horwitz, G.A., Prezant, T.R., Valentini, A., Nakashima, M., Bronstein, M.D. & Melmed, S. (1999b) Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Molecular Endocrinology, 13, 156-166.
33. Zou, H., McGarry, T.J., Bernal, T. & Kirschner, M.W. (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science, 285, 418-422.
34. Zur, A. & Brandeis, M. (2001) Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis. EMBO Journal, 20, 792-801.